Prostate Risks Similar for Testosterone Therapy and Placebo

For men with hypogonadism and low prostate cancer risk, TRT didn't increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.

Related Keywords

Boston ,Massachusetts ,United States ,Shalender Bhasin ,Harvard Medical School ,Testosterone Replacement Therapy ,Long Term Vascular Events ,Efficacy Response ,Hypogonadal Men ,Hypogonadism ,Prostate Carcinoma ,Alignant Prostate Neoplasm ,Prostate Cancer ,Ancer Of The Prostate ,Prostatic ,Benign Prostatic Hyperplasia ,Bph ,Benign Prostatic Hypertrophy ,Ph Benign Prostatic Hyperplasia ,Odular Hyperplasia ,Ep Benign Enlargement Of The Prostate ,Prostate Specific Antigen ,Sa ,Sa Prostate Specific Antigen ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,